Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluation of a 3D-Printed Stent-Graft for Aortic Aneurysms

Official title: Evaluation of Clinical Efficacy and Safety of Aortal Stent-graft Modelled Printing 3D Model Printing Technology - Multicenter, Randomized Clinical Trial

Run by Samodzielny Publiczny Szpital Kliniczny nr 2 PUM · NCT06969729 · Data updated 2026-11-12

This study is testing a new 3D-printed stent-graft to see if it works better and is safer than standard devices for treating complex abdominal aortic aneurysms in about 100 patients.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorSamodzielny Publiczny Szpital Kliniczny nr 2 PUM
Academic / other
Locations1 site (Szczecin, West Pomeranian Voivodeship)
StatusRecruiting
StartedNovember 1, 2022
Main results expectedApril 30, 2027
Study endsApril 30, 2027
Registry record updatedApril 16, 2026
Trial IDNCT06969729 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with specific types of abdominal aortic aneurysms or endoleaks that meet the study criteria.

Probably not a fit

Patients under 18, pregnant or breastfeeding women, and those with allergies to stent materials or contraindications to anticoagulation will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial compares the efficacy and safety of a physician-modified stent-graft created using 3D printing technology against standard custom-made devices for treating complex abdominal aortic aneurysms. It is a randomized, multicenter, open-label study involving approximately 100 patients, who will be assigned to either the innovative intervention or the standard procedure. The study includes a screening phase, intervention phase, and a 12-month safety follow-up to assess outcomes. Randomization will help minimize bias and ensure balanced characteristics among treatment groups.

Why it matters

Potential benefit: If successful, this approach could provide a more effective and tailored treatment option for patients with complex aortic aneurysms.

How similar studies have gone: While the use of 3D printing in medical devices is gaining traction, this specific approach to treating aortic aneurysms is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Female and male subjects age ≥ 18 2. Subject need to meet one of the following criteria:

* Subjects with juxtarenal or suprarenal abdominal aortic aneurysm, type IV thoracoabdominal aneurysm of diameter \>5.5cm (male) and 5.2cm (female)
* Subjects with juxtarenal or suprarenal abdominal aortic aneurysm, type IV thoraco-abdominal aneurysm with aneurysm growth rate ≥ 0.5cm during 6 months
* Type IA endoleak of post-implantation of abdominal stent- graft 3. Iliac arteries morphology with aortic stent graft implantation to be restored 4. Aortic segment which is proximal to aneurysm
* Length ≥20mm
* Diameter 20mm-36mm
* Aortic suprarenal angle ≤75 degrees 5. Survival \> 2 years

Exclusion Criteria:

1. Female and male subjects age \<18
2. Pregnancy and breast feeding
3. Allergy and hypersensitivity to matherials of which the stent- graft is composed
4. Hypersensitivity and contraindication to anti coagulation or contrast application to angio - CT which cannot be eliminated medically
5. Coagulopathy which cannot medically treated
6. Active infection which might cause stent - graft infection
7. Creatinine level \> 3.0mg/dL
8. Marphan syndrome, Ehlers - Denlos syndrome
9. Unstable angina pectoris
10. Raptured aortic aneurysm caused by cardiac insufficiency
11. Unwillingness to comply with protocol procedures
12. Iliac arteries morphology adequate for stent-graft implantation
13. The diameter of the aortic flow lumen in reno-visceral aorta greater than 34mm
14. Aortic section which is proximal to celiac artery with significant number of thrombi, calcification or changed by aneurysm
15. Aorta with significant number of irregular thrombi which may lead to embolism ("shaggy aorta")
16. Diameter of proximal kidney arteries which is exercisable to stenting \<4.5mm
17. Devision of kidney artery which is exercisable to stenting in the distance of \<1cm of celiac artery, each of them is is in \<4.5mm in diameter
18. Atypical anatomy of celiac artery in the form of separate exit of splenic and hepatic aortic artery

Where it's running

  • An Independent Clinical Hospital 2 PUM
    Szczecin, West Pomeranian Voivodeship, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.